Sagimet Biosciences (NASDAQ:SGMT – Get Free Report) is expected to release its earnings data before the market opens on Monday, March 24th. Analysts expect Sagimet Biosciences to post earnings of ($0.65) per share for the quarter.
Sagimet Biosciences (NASDAQ:SGMT – Get Free Report) last issued its earnings results on Wednesday, March 12th. The company reported ($0.50) EPS for the quarter, topping analysts’ consensus estimates of ($0.65) by $0.15. On average, analysts expect Sagimet Biosciences to post $-2 EPS for the current fiscal year and $-4 EPS for the next fiscal year.
Sagimet Biosciences Trading Up 6.6 %
Shares of SGMT stock opened at $3.74 on Monday. The firm has a fifty day moving average price of $4.28 and a 200 day moving average price of $4.46. The company has a market cap of $114.72 million, a P/E ratio of -2.62 and a beta of 2.57. Sagimet Biosciences has a 12 month low of $2.39 and a 12 month high of $7.38.
Analyst Ratings Changes
Check Out Our Latest Analysis on Sagimet Biosciences
About Sagimet Biosciences
Sagimet Biosciences Inc, a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic pathways in the United States. The company’s lead drug candidate is Denifanstat, a once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction associated steatohepatitis.
See Also
- Five stocks we like better than Sagimet Biosciences
- What Is WallStreetBets and What Stocks Are They Targeting?
- How to Build the Ultimate Everything ETF Portfolio
- Consumer Staples Stocks, Explained
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- What is an Earnings Surprise?
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Sagimet Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sagimet Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.